Octreotide
Sandostatin · Octreotide acetate
A synthetic somatostatin analog approved for acromegaly and for symptoms associated with certain neuroendocrine tumours. It suppresses growth hormone release, the opposite direction to the secretagogues in this category.
Tracking and educational reference only, on values you enter yourself. Not medical advice or a dosing recommendation.
Half-life
~1.7-1.9 h, injection. Half-life is an educational pharmacology figure, drawn from public sources, and is not a schedule or dosing instruction.
Storage & handling
Supplied as a solution in a single-dose vial; refrigerated and protected from light per its label.
References
- FDA label: octreotide acetate injection (ANDA 075957)
Read the source
Related in Growth Hormone
Educational reference only, compiled from public sources. Not medical advice, diagnosis, treatment, or a dosing recommendation, and not a recommendation to use any compound. Many compounds listed are research materials not approved for human use. Consult a qualified professional.